Baldwin et al., 1972 - Google Patents
Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexesBaldwin et al., 1972
- Document ID
- 5604677584237300179
- Author
- Baldwin R
- Price M
- Robins R
- Publication year
- Publication venue
- Nature New Biology
External Links
Snippet
LYMPHOCYTES from tumour-bearing animals are often cytotoxic in vitro against cultured tumour cells from the same individual1–4. It is possible that the serum of tumour-bearing hosts may contain circulating factors which interfere with the cell-mediated immune …
- 210000004027 cells 0 title abstract description 34
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48369—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying part being an antibody, an immunoglobulin, or a fragment thereof, e.g. a Fc-fragment
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Baldwin et al. | Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes | |
US4844893A (en) | EX vivo effector cell activation for target cell killing | |
KR100667121B1 (en) | Compositions and Methods for Treating Viral Infections | |
Banjo et al. | Immunologically active heterosaccharides of carcinoembryonic antigen of human digestive system | |
Watson et al. | Extra-nuclear location of histones in activated human peripheral blood lymphocytes and cultured T-cells | |
Berneman et al. | Natural mouse IgG reacts with self antigens including molecules involved in the immune response | |
Tamerius et al. | Tumor-associated blocking factors: isolation from sera of tumor-bearing mice | |
EP0764030A1 (en) | Use of autoantibodies for tumor therapy and prophylaxis | |
EP1241264A1 (en) | Monoclonal antibodies to colon cancer antigen | |
Kemp et al. | Evidence for adsorption of heterospecific host immunoglobulin on the tegument of Schistosoma mansoni | |
Stettin et al. | Anti-mistletoe lectin antibodies are produced in patients during therapy with an aqueous mistletoe extract derived from Viscum album L. and neutralize lectin-induced cytotoxicity in vitro | |
JP3429281B2 (en) | Use and detection method of urine-related antigen and antigen subunit | |
US20150183843A1 (en) | Glycoproteins having lipid mobilising properties and therapeutic applications thereof | |
Saal et al. | Lymphocytes with T-cell markers cooperate with IgG antibodies in the lysis of human tumour cells | |
EP0300031A1 (en) | Immunosuppressive peptides and methods of use | |
KR100454554B1 (en) | New Peptides, Compositions, Methods and Kits Derived from Human Heat Shock Protein 60 for Diabetes Treatment | |
Chism et al. | Immunogenicity of oncofetal antigens: a review | |
Chard et al. | Enhancement of the C57BL leukemia EL 4 by Fab fragments of isoantibody | |
Herkel et al. | Humoral mechanisms in T cell vaccination: induction and functional characterization of anti-lymphocytic autoantibodies | |
AU5984494A (en) | Prevention of suppression of immune defense against cancer caused by the cancer-associated scm-recognition peptides | |
Levy | Cell-mediated cytotoxicity and serum-mediated blocking: evidence that their associated determinants on human tumor cells are different | |
JPH05502854A (en) | Tolerogenic immunoglobulin-protein conjugate | |
Morgan et al. | “Hidden” cytotoxic antibodies that react with allogeneic cultured fetal and tumor cells contained in soluble immune complexes from normal human sera | |
Klein et al. | Anti‐mitochondrial antibodies (anti‐M7) in heart diseases recognize epitopes on bacterial and mammalian sarcosine dehydrogenase | |
Bakouche et al. | Presentation of an MuLV-related tumour antigen in liposomes as a potent tertiary immunogen after adoptive transfer. |